Longevity Treatment Guides

Darker skin raises PIH risk after energy devices. Fitzpatrick type is a start, not a license. See a licensed clinician who can adjust settings and cancel unsafe plans.

Devices and injections can modestly smooth cellulite, often temporarily. It is not a disease. See a licensed clinician and keep expectations realistic.

Herbs and supplements can change how medicines work and vary in quality. St. John’s wort, bleeding-risk herbs, and contaminated products need a pharmacist or clinician review before you add them.

Complementary care is used with standard treatment. Alternative care replaces it. Integrative care coordinates both. The main harm is delay of indicated medical care.

Placebo and context effects can change how symptoms feel without proving a specific mechanism. Feeling better after a visit does not make delayed diagnosis or skipped treatment safe.

Most nootropics are not FDA-approved cognition drugs. Prescription stimulants need a clinician. Watch interactions, contamination, and disease-treatment claims on supplement labels.

Start with hearing, sleep, blood pressure, activity, mood, and medicines. Devices and nootropics come last, with limited evidence, and they do not replace a workup.

Brain-training apps and wearables rarely transfer to everyday thinking. They are not a diagnosis. Ask what the claim is, and who stores your cognitive data.

Brown-fat and metabolism claims from cold plunges are overstated. Cold shock can stress the heart. Cold exposure is not a lifespan treatment.

Cold dose is time, temperature, and skin protection—not toughness. After strength training, immersion may blunt hypertrophy. Stop for numbness or mottling.

Whole-body cryotherapy evidence is limited. Poorly run nitrogen chambers can cause frostbite or asphyxia. Short-term soreness relief is not a longevity treatment.

Activated charcoal can bind some swallowed poisons in emergency care. Wellness binder stacks can also bind medicines and are not a proven everyday detox.

EDTA, DMSA, and DMPS are prescription drugs for documented metal poisoning. Wellness chelation has FDA warnings and real toxicity—not a fatigue protocol.

Blood or urine tests help when a metal and exposure are specified. Provoked urine panels after a chelator are misleading and should not start treatment.

Detox diets, foot baths, and coffee enemas lack evidence they remove toxins. Enemas can injure the bowel. Foot-bath color comes from the electrodes.

A false positive is a wrong alarm. Overdiagnosis finds real disease that would never have harmed you. Incidental findings start cascades you should plan before testing.

A lab reference interval is not a wellness “optimal” range. Treating numbers without a clinical indication can mean unnecessary drugs, procedures, and harm.

Chronological age is calendar time. Biological-age scores are model estimates with limited clinical action. They should not replace recommended screening or treatment.

Cardiorespiratory fitness associates with better outcomes. A lab CPET is not a wristwatch estimate. Training can raise fitness; it is not a lifespan guarantee.

Separate USPSTF and indicated labs from boutique longevity panels. More markers do not mean better care. Ask which result will change a clinical decision this year.

Static magnet wraps and jewelry have weak evidence for pain. Some implants and pacemakers are contraindications, depending on the product. Do not delay indicated care.

510(k) clearance is not proof a device works for every marketed use. Some bone-growth stimulators have labeled indications. Wellness PEMF mats are a different category.

Frequency, intensity, waveform, duty cycle, and session time are not interchangeable knobs. Consumer presets often differ from the parameters used in clinical trials.

Supplement plans can cause interactions, contamination, liver injury, bleeding, or duplicate doses. FDA does not approve supplements to treat disease.

Organic-acid, stool, hormone-metabolite, food-IgG, and microbiome panels vary in validity. CLIA status does not prove a specialty lab is clinically useful.

Root-cause talk can help or oversimplify. Intestinal permeability is real in selected disease; leaky gut syndrome and adrenal fatigue are not universal diagnoses.

Trials support coaching for diabetes prevention and habit change, with real limits. Coaching is not a disease treatment by itself and should sit beside licensed care.

Certification is not a license. Learn how NBHWC credentials, coaching scope, and red flags help you tell a coach from a clinician who can diagnose or prescribe.

Separate established prevention—activity, sleep, tobacco, blood pressure—from speculative anti-aging products and biological-age marketing that outrun the evidence.

Lifestyle medicine organizes care around nutrition, activity, sleep, stress, social connection, and avoiding risky substances. The evidence is strong in places and limited in others.

Longevity treatments are not one therapy. Safety depends on the intervention, indication, clinician, and monitoring. Established prevention and speculative add-ons do not share a risk profile.

A longevity protocol should start from history, indicated tests, and your goals—not a purchased stack. Personalization means matching care to you. It is not the same as ordering more laboratories.

Chest pain, neurologic deficits, gastrointestinal bleeding, and suicidal ideation need emergency or specialty care, not a naturopathic visit as the first stop.

Naturopathic titles, diagnosis, and prescribing depend on the state. Start with jurisdiction, then verify education, examination, and what that license actually allows.

A useful supplement review covers the product, dose, indication, your medicines, and quality testing. FDA does not approve supplements to treat disease.

Reliable evidence does not support homeopathy beyond placebo. The larger risks are delayed medical care and, for some products, contamination or mislabeling.

FDA clearance, approval, and wellness claims are different. Status is indication-specific. A home tDCS kit is not equivalent to clinic TMS used under a psychiatric protocol.

Neurological optimization is a marketing term. Sleep, exercise, and vascular-risk care have stronger evidence than unproven brain-stimulation packages sold as cognitive upgrades.

CGM is useful in diabetes care; wellness CGM evidence is limited. Micronutrient, microbiome, and genetic food tests often lack clinical validity.

Hospital HBOT uses hard chambers at UHMS pressures for named indications. Mild soft chambers are not the same treatment. Barotrauma, fire, and oxygen toxicity are real risks.

FDA has not approved ozone to treat diseases. Insufflation and autohemotherapy can cause gas embolism or infection. Inhaled ozone irritates lungs and is not a therapy.

Few peptides sold in clinics are FDA-approved medicines. Compounded and research products vary in quality. Ask the indication, the legal status, and what testing the lot actually received.

503A and 503B compounding are not FDA approval. Ask for the named pharmacy, a lot-specific COA, sterility results for injections, and a beyond-use date. Quality still varies by product and process.

VO2, strength, and movement screens are useful when they change the next training block. Wearable vanity metrics are not a program and do not replace clinical evaluation.

Biohacking is a marketing term spanning sleep and nutrition habits to unregulated self-experimentation. Start with licensed care and established habits. Do not begin with DIY peptides or hormones.

Separate short-term soreness relief from faster healing, better function, or injury prevention. Sleep, load, and rehab usually outrank gadgets.

FDA approval is not clinic registration. Most marketed stem-cell and exosome products are unapproved 351 biologics, not qualifying 361 HCT/Ps.

PRP, PRF, BMAC, and donor birth-tissue products are different. Autologous is not automatically safer. Evidence is mixed, and FDA product rules still apply.

Laser, radiofrequency, PRP shots, and fillers are often sold for GSM, desire, or ED. Many lack strong evidence. FDA has warned about vaginal energy devices. Start with a licensed exam.

ASFA Categories I–IV rate medical TPE indications. Wellness longevity is not an ASFA indication. TPE is a specialty procedure with infection, clotting, and access risks.

Plasma exchange for longevity rests on animal work and early human studies. It is costly, speculative, and not proven preventive care. Infection and clotting remain risks.

Centrifugal and membrane TPE both remove plasma. Efficiency, access, and citrate load differ. Neither method is a proven aging treatment. Hospital specialty care.

FDA-approved GLP-1 medicines are not the same as compounded copies. Watch GI effects, gallbladder risk, pregnancy, and lean-mass loss. Monitoring and resistance training matter.